Turbogen director reports options on 30,177 shares
Turbogen Ltd. (TRBG) reported the initial holdings of director Eli Zooker.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Turbogen Ltd. (TRBG) reported the initial holdings of director Eli Zooker. He holds a share option to acquire 30,177 ordinary shares at an exercise price of $2.99 per share, granted on March 9, 2025 and expiring on March 9, 2032. The options vest in three equal installments of 33.3% beginning March 9, 2025; as of August 25, 2026, 20,118 options are fully vested and none have been exercised.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Zooker Eli
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share option (right to buy) F2, F1 | -- | -- | -- |
Holdings After Transaction:
Share option (right to buy) — 30,177 contracts (Direct)
Footnotes (2)
- F1. A total of 30,177 options were granted on March 9, 2025 and vest in three equal installments of 33.3% beginning March 9, 2025. As of August 25, 2026, 20,118 options are fully vested and none have been exercised into ordinary shares.
- F2. The options were granted with an exercise price of NIS 8.95 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $2.99 per share.
Key Figures
Underlying ordinary shares subject to option: 30,177 shares
Vested options as of August 25, 2026: 20,118 options
Exercise price (original currency): NIS 8.95 per share
+3 more
6 metrics
Underlying ordinary shares subject to option
30,177 shares
Share option (right to buy) held directly by director Eli Zooker
Vested options as of August 25, 2026
20,118 options
Portion of the 30,177 options that are fully vested
Exercise price (original currency)
NIS 8.95 per share
Grant exercise price before FX conversion
Exercise price (USD, Form 3 basis)
$2.99 per share
Converted using NIS 2.994 to USD $1.00 as of August 24, 2026
Exchange rate used
NIS 2.994 to USD $1.00
Rate used to convert NIS 8.95 exercise price into $2.99
Option expiration date
March 9, 2032
Expiration of the reported share option (right to buy)
Key Terms
Share option (right to buy), exercise price, vesting, ordinary shares, +1 more
5 terms
exercise price financial
"options were granted with an exercise price of NIS 8.95 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"options were granted on March 9, 2025 and vest in three equal installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exchange rate financial
"exercise price converted using an exchange rate of NIS 2.994 to USD $1.00"
Exchange rate is the price of one currency expressed in another—for example, how many euros you receive for one US dollar. It matters to investors because changes in that price alter the reported profits, costs and value of assets for companies and portfolios that operate or hold money across borders; think of it like switching measurement units, where the same item can look bigger or smaller depending on the unit used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who is the reporting insider in Turbogen Ltd. (TRBG)'s Form 3?
The reporting insider is Eli Zooker, who is disclosed as a director of Turbogen Ltd. He filed an initial statement of beneficial ownership reporting his holdings of stock options relating to the company’s ordinary shares.
What options does Eli Zooker report holding in TRBG on this Form 3?
Eli Zooker reports holding a share option covering 30,177 underlying ordinary shares of Turbogen Ltd. The option represents his right to buy those shares if he chooses to exercise it before expiration, subject to the vesting schedule described.
What is the exercise price of Eli Zooker’s options in Turbogen Ltd. (TRBG)?
The options were granted with an exercise price of NIS 8.95 per share, which for this Form 3 was converted using an exchange rate of NIS 2.994 to USD $1.00, resulting in an exercise price of $2.99 per share.
How do Eli Zooker’s TRBG options vest and how many are vested?
The 30,177 options vest in three equal installments of 33.3% beginning March 9, 2025. As of August 25, 2026, 20,118 options are fully vested and none have been exercised into ordinary shares.
When do Eli Zooker’s options in Turbogen Ltd. (TRBG) expire?
The options reported by Eli Zooker expire on March 9, 2032. He may exercise vested portions of the option prior to that expiration date, consistent with the terms and vesting schedule described in the disclosure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
